Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Papi

Showing results (121-130 of 428) with videos related to

Pageof 43
Sort By:
The Journal of Infectious Diseases|January 3, 2006
Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokinesLuminita A Stanciu, Cinzia M Bellettato, Vasile Laza-Stanca, et al.
BMC Pulmonary Medicine|December 30, 2019
Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthmaRichard Beasley, James Harper, Grace Bird, et al.
Clinics in Chest Medicine|August 30, 2012
Asthma: a chronic infectious disease?Gaetano Caramori, Nikos Papadopoulos, Marco Contoli, et al.
European Clinical Respiratory Journal|February 23, 2023
Fixed-dose combination fluticasone/formoterol for asthma treatment in a real-world setting: meta-analysis of exacerbation rates and asthma controlAlberto Papi, Murtaza Qasuri, Ernestine Chung, et al.
European Journal of Internal Medicine|August 20, 2017
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patientsMarco Contoli, Gianluca Campo, Rita Pavasini, et al.
Archivos De Bronconeumologia|March 30, 2024
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analysesAlberto Papi, Franco Alfano, Tommaso Bigoni, et al.
Respiratory Research|August 1, 2019
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCAFrank C Albers, Alberto Papi, Camille Taillé, et al.
The European Respiratory Journal|January 11, 2020
ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthmaRichard Beasley, Irene Braithwaite, Alex Semprini, et al.
COPD|March 17, 2015
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPDGianluca Campo, Rita Pavasini, Michele Malagù, et al.
ERJ Open Research|May 25, 2023
Comparison of the Asthma Control Questionnaire and patient diaries in uncontrolled asthmaDave Singh, Alberto Papi, Guy Brusselle, et al.
Pageof 43

Showing results (121-130 of 428) with videos related to

Sort By:
Pageof 43
The Journal of Infectious Diseases|January 3, 2006
Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokinesLuminita A Stanciu, Cinzia M Bellettato, Vasile Laza-Stanca, et al.
BMC Pulmonary Medicine|December 30, 2019
Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthmaRichard Beasley, James Harper, Grace Bird, et al.
Clinics in Chest Medicine|August 30, 2012
Asthma: a chronic infectious disease?Gaetano Caramori, Nikos Papadopoulos, Marco Contoli, et al.
European Clinical Respiratory Journal|February 23, 2023
Fixed-dose combination fluticasone/formoterol for asthma treatment in a real-world setting: meta-analysis of exacerbation rates and asthma controlAlberto Papi, Murtaza Qasuri, Ernestine Chung, et al.
European Journal of Internal Medicine|August 20, 2017
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patientsMarco Contoli, Gianluca Campo, Rita Pavasini, et al.
Archivos De Bronconeumologia|March 30, 2024
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analysesAlberto Papi, Franco Alfano, Tommaso Bigoni, et al.
Respiratory Research|August 1, 2019
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCAFrank C Albers, Alberto Papi, Camille Taillé, et al.
The European Respiratory Journal|January 11, 2020
ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthmaRichard Beasley, Irene Braithwaite, Alex Semprini, et al.
COPD|March 17, 2015
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPDGianluca Campo, Rita Pavasini, Michele Malagù, et al.
ERJ Open Research|May 25, 2023
Comparison of the Asthma Control Questionnaire and patient diaries in uncontrolled asthmaDave Singh, Alberto Papi, Guy Brusselle, et al.
Pageof 43